ABBV-295 Clinical Trials
3 recruitingDrug
Phase 13
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.
Healthy Volunteer
AbbVie24 enrolled1 locationNCT07514260
Recruiting
Phase 1
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
Healthy Volunteer
AbbVie20 enrolled1 locationNCT07414784
Recruiting
Phase 1
A Study of ABBV-295 Subcutaneous Injections to Assess Adverse Events and Pharmacokinetics in Adult Participants With Obesity
Obesity
AbbVie96 enrolled1 locationNCT07291232